These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 36324348)

  • 1. Comparison of Efficacy and Safety of Anticoagulant Monotherapy and Combined Therapy of Anticoagulant and Antiplatelets in Patients With Stable Coronary Artery Disease and Atrial Fibrillation: A Meta-Analysis.
    Tentu N; Ijaz A; Batool S; Khan RS; Mohammed F; Khan MH; Sandhu QI; Ali N
    Cureus; 2022 Sep; 14(9):e29772. PubMed ID: 36324348
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dual therapy with oral anticoagulation and single antiplatelet agent versus monotherapy with oral anticoagulation alone in patients with atrial fibrillation and stable ischemic heart disease: a systematic review and meta-analysis.
    Shakir A; Khan A; Agarwal S; Clifton S; Reese J; Munir MB; Nasir UB; Khan SU; Gopinathannair R; DeSimone CV; Deshmukh A; Jackman WM; Stavrakis S; Asad ZUA
    J Interv Card Electrophysiol; 2023 Mar; 66(2):493-506. PubMed ID: 36085242
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Meta-Analysis of Oral Anticoagulant Monotherapy as an Antithrombotic Strategy in Patients With Stable Coronary Artery Disease and Nonvalvular Atrial Fibrillation.
    Lee SR; Rhee TM; Kang DY; Choi EK; Oh S; Lip GYH
    Am J Cardiol; 2019 Sep; 124(6):879-885. PubMed ID: 31311662
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Safety and efficacy of anticoagulant monotherapy in atrial fibrillation and stable coronary artery disease: A systematic review and meta-analysis.
    Ullah W; Sattar Y; Shaukat M; Fischman DL
    Eur J Intern Med; 2020 Nov; 81():54-59. PubMed ID: 32709546
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Meta-Analysis Comparing Oral Anticoagulant Monotherapy Versus Dual Antithrombotic Therapy in Patients With Atrial Fibrillation and Stable Coronary Artery Disease.
    Ahmed M; Ahsan A; Shafiq A; Ahmed R; Alam M; Sabouret P; Rana JS; Fonarow GC
    Clin Cardiol; 2024 Oct; 47(10):e70026. PubMed ID: 39373259
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Vitamin K antagonists with or without long-term antiplatelet therapy in outpatients with stable coronary artery disease and atrial fibrillation: Association with ischemic and bleeding events.
    Lemesle G; Ducrocq G; Elbez Y; Van Belle E; Goto S; Cannon CP; Bauters C; Bhatt DL; Steg PG;
    Clin Cardiol; 2017 Oct; 40(10):932-939. PubMed ID: 28692742
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Oral anticoagulation and antiplatelets in atrial fibrillation patients after myocardial infarction and coronary intervention.
    Lamberts M; Gislason GH; Olesen JB; Kristensen SL; Schjerning Olsen AM; Mikkelsen A; Christensen CB; Lip GY; Køber L; Torp-Pedersen C; Hansen ML
    J Am Coll Cardiol; 2013 Sep; 62(11):981-9. PubMed ID: 23747760
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Management of stable coronary artery disease and atrial fibrillation with anti-thrombotic therapy: A systematic review and meta-analysis.
    Malladi S; Hamid K; Pendyala NC; Veerapaneni V; Deliwala S; Dubre D; Elian SA; Singh A
    Medicine (Baltimore); 2021 Dec; 100(48):e27498. PubMed ID: 35049165
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Open-Label Randomized Trial Comparing Oral Anticoagulation With and Without Single Antiplatelet Therapy in Patients With Atrial Fibrillation and Stable Coronary Artery Disease Beyond 1 Year After Coronary Stent Implantation.
    Matsumura-Nakano Y; Shizuta S; Komasa A; Morimoto T; Masuda H; Shiomi H; Goto K; Nakai K; Ogawa H; Kobori A; Kono Y; Kaitani K; Suwa S; Aoyama T; Takahashi M; Sasaki Y; Onishi Y; Mano T; Matsuda M; Motooka M; Tomita H; Inoko M; Wakeyama T; Hagiwara N; Tanabe K; Akao M; Miyauchi K; Yajima J; Hanaoka K; Morino Y; Ando K; Furukawa Y; Nakagawa Y; Nakao K; Kozuma K; Kadota K; Kimura K; Kawai K; Ueno T; Okumura K; Kimura T;
    Circulation; 2019 Jan; 139(5):604-616. PubMed ID: 30586700
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Combined anticoagulation and antiplatelet therapy for high-risk patients with atrial fibrillation: a systematic review.
    Lane DA; Raichand S; Moore D; Connock M; Fry-Smith A; Fitzmaurice DA;
    Health Technol Assess; 2013 Jul; 17(30):1-188. PubMed ID: 23880057
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Anticoagulation With or Without Antiplatelet Therapy Following Transcatheter Aortic Valve Replacement for Patients With Atrial Fibrillation: A Meta-Analysis.
    Yokoyama Y; Briasoulis A; Takagi H; Kuno T
    Cardiovasc Revasc Med; 2021 Mar; 24():42-47. PubMed ID: 32830088
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Medical and interventional outcome of dissection of the cervical arteries: Systematic review and meta-analysis.
    Pini R; Faggioli G; Lodato M; Campana F; Vacirca A; Gallitto E; Gargiulo M
    J Vasc Surg; 2024 Sep; 80(3):913-921.e13. PubMed ID: 38636608
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Outcomes of anticoagulated patients with atrial fibrillation treated with or without antiplatelet therapy - A pooled analysis from the PREFER in AF and PREFER in AF PROLONGATON registries.
    Patti G; Pecen L; Lucerna M; Huber K; Rohla M; Renda G; Siller-Matula J; Schnabel RB; Cemin R; Kirchhof P; De Caterina R
    Int J Cardiol; 2018 Nov; 270():160-166. PubMed ID: 30220376
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Net clinical benefit of antithrombotic therapy for atrial fibrillation patients with stable coronary artery disease.
    Lee SR; Jung JH; Choi EK; Lee SW; Kwon S; Park JS; Kang J; Han KD; Park KW; Oh S; Lip GYH
    Front Cardiovasc Med; 2022; 9():991293. PubMed ID: 36072876
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antithrombotic Therapy for Chronic Kidney Disease Patients With Concomitant Atrial Fibrillation and Coronary Artery Disease.
    Lee KH; Ou SM; Chu YC; Lin YP; Tsai MT; Tarng DC
    Front Cardiovasc Med; 2021; 8():751359. PubMed ID: 34692798
    [No Abstract]   [Full Text] [Related]  

  • 16. Oral Anticoagulation for Patients With Atrial Fibrillation on Long-Term Hemodialysis.
    Kuno T; Takagi H; Ando T; Sugiyama T; Miyashita S; Valentin N; Shimada YJ; Kodaira M; Numasawa Y; Briasoulis A; Burger A; Bangalore S
    J Am Coll Cardiol; 2020 Jan; 75(3):273-285. PubMed ID: 31976865
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effectiveness and safety of oral anticoagulant therapy in patients with atrial fibrillation with prior gastrointestinal bleeding: A systematic review and meta-analysis.
    Zhao J; Wu X; Li S; Gu Q
    Front Cardiovasc Med; 2022; 9():937320. PubMed ID: 35966547
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Combined aspirin and anticoagulant therapy in patients with atrial fibrillation.
    So CH; Eckman MH
    J Thromb Thrombolysis; 2017 Jan; 43(1):7-17. PubMed ID: 27665101
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Meta-Analysis of Antithrombotic Therapy in Atrial Fibrillation After Percutaneous Coronary Intervention.
    Khan SU; Khan MU; Ghani AR; Lone AN; Arshad A; Kaluski E
    Am J Cardiol; 2018 May; 121(10):1200-1206. PubMed ID: 29548674
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Optimal long-term antithrombotic treatment of patients with stable coronary artery disease and atrial fibrillation: "OLTAT registry".
    Fischer Q; Georges JL; Le Feuvre C; Sharma A; Hammoudi N; Berman E; Cohen S; Jolivet I; Silvain J; Helft G
    Int J Cardiol; 2018 Aug; 264():64-69. PubMed ID: 29776575
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.